In particular, DHX15 and DHX9 were almost exclusively expressed in high-risk MDS cases and DHX15 was significantly upregulated in LSCs, compared to Blast (Fig. 7c and Supplement figure 8). Here, DHX9 is linked to myelodysplastic syndrome.